Gallego Patricia H, Craig Maria E, Duffin Anthony C, Bennetts Bruce, Jenkins Alicia J, Hofer Sabine, Lam Albert, Donaghue Kim C
Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Diabetes Care. 2008 Aug;31(8):1585-9. doi: 10.2337/dc07-2236. Epub 2008 May 9.
In type 1 diabetes, plantar fascia, a collagen-rich tissue, is susceptible to glycation and oxidation. Paraoxonase-1 (PON1) is an HDL-bound antioxidant enzyme. PON1 polymorphisms have been associated with susceptibility to macro- and microvascular complications. We investigated the relationship between plantar fascia thickness (PFT) and PON1 gene variants, p.Leu54Met, p.Gln192Arg, and c.-107C>T, in type 1 diabetes.
This was a cross-sectional study of 331 adolescents with type 1 diabetes (162 male and 169 female). PFT was assessed by ultrasound, PON1 was assessed by genotyping with PCR and restriction fragment-length polymorphism, and serum PON1 activity was assessed by rates of hydrolysis of paraoxon and phenylacetate.
Median (interquartile range) age was 15.4 (13.5-17.3) years, and diabetes duration was 7.6 (4.9-10.6) years. The distribution of p.Leu54Met genotypes was LL 135 (40.8%), ML 149 (45%), and MM 47 (14.2%). PFT was abnormal (>1.7 mm) in 159 adolescents (48%). In multivariate analysis, predictors of abnormal PFT were ML/LL versus MM p.Leu54Met polymorphism (odds ratio 3.84 [95% CI 1.49-9.82], P = 0.005); BMI (percentile) (1.02 [1.01-1.03], P = 0.007); systolic blood pressure (percentile) (1.01 [1.00-1.02], P = 0.03); and male sex (3.29 [1.98-5.46], P < 0.001).
Thickening of the plantar aponeurosis occurs predominantly in overweight and male adolescents with type 1 diabetes. The MM genotype at PON1 p.Leu54Met is associated with a reduced risk of abnormal PFT.
在1型糖尿病中,富含胶原蛋白的足底筋膜易发生糖基化和氧化。对氧磷酶-1(PON1)是一种与高密度脂蛋白结合的抗氧化酶。PON1基因多态性与大血管和微血管并发症的易感性有关。我们研究了1型糖尿病患者足底筋膜厚度(PFT)与PON1基因变异p.Leu54Met、p.Gln192Arg和c.-107C>T之间的关系。
这是一项对331名1型糖尿病青少年(162名男性和169名女性)的横断面研究。通过超声评估PFT,通过聚合酶链反应和限制性片段长度多态性基因分型评估PON1,并通过对氧磷和苯乙酸的水解速率评估血清PON1活性。
中位(四分位间距)年龄为15.4(13.5 - 17.3)岁,糖尿病病程为7.6(4.9 - 10.6)年。p.Leu54Met基因型的分布为LL 135例(40.8%),ML 149例(45%),MM 47例(14.2%)。159名青少年(48%)的PFT异常(>1.7 mm)。在多变量分析中,PFT异常的预测因素为ML/LL与MM的p.Leu54Met多态性(比值比3.84 [95%可信区间1.49 - 9.82],P = 0.005);体重指数(百分位数)(1.02 [1.01 - 1.03],P = 0.007);收缩压(百分位数)(1.01 [1.00 - 1.02],P = 0.03);以及男性性别(3.29 [1.98 - 5.46],P < 0.001)。
1型糖尿病超重和男性青少年中主要出现足底腱膜增厚。PON1 p.Leu54Met的MM基因型与PFT异常风险降低相关。